// App-Quantinova.ai

: Effect of severity of exacerbations of COPD and hospitalised pneumonia on risk of myocardial infarction

Researchers

Presenter

  • Kieran Rothnie

Principal Investigators

  • Hana Mllerov

  • Liam Smeeth

  • Neil Pearce

  • Ian Douglas

  • Jennifer Quint

Medical Centers

  • GlaxoSmithKline, London, United Kingdom

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • GlaxoSmithKline plc(GSK) and Meritorious Reserved Category (MRC)

Result

  • N/A